Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- FDA Gives GSK a Lesson in Prostate Geometry
- The FDA gave GlaxoSmithKline a lesson in geometry last week when it sent the company a warning letter over its "misleading" claims for Avodart, a prostate reduction drug. FDA's main objection was the scale of the animation in the Avodart ad that was supposed to represent a...
- Blog posts 2009-03-02
Additional Resources
- FDA Approves GlaxoSmithKline's Avodart, The First Dual-Acting 5 Alpha-Reductase Inhibitor for Benign Prostatic Hyperplasia, BPH
- Business Editors
- Research articles 2002-10-10
- GSK steps along desired path of evolution
- Andrew Witty, chief executive of GlaxoSmithKline, said on Wednesday that the group's traditional core market of prescription medicines in developed countries may fall to just a quarter of total sales. He also said that further diversification would focus more on revenue growth than profit margins. Unveiling third-quarter results, Mr Witty,...
- News items 2009-10-28
- << Previous
- page 1 of 1
- Next >>
